Novo CEO signals M&A opportunities to strengthen drug pipeline

According to a report by CNBC… Novo CEO Mike Doustdar told CNBC that it is considering M&A opportunities as it faces growing competition in the weight-loss market. complete report is on link below: Source: https://www.cnbc.com/2026/09/22/novo-nordisk-ceo-interview-weight-loss-drugs-strategy.html